학술논문
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
Document Type
Article
Author
Oliver-Caldés, A.; Español-Rego, M.; Varea, S.; Rosiñol, L.; Tovar, N.; Jiménez, R.; Rodríguez-Lobato, L.G.; Olesti, E.; Calvo-Orteu, M.; Delgado, J.; Sáez-Peñataro, J.; Juan, M.; Pascal, M.; Urbano-Ispizua, A.; Fernández de Larrea, C.; González-Calle, V.; López-Corral, L.; López-Parra, M.; Mateos, M.-V.; Cabañas, V.; Sánchez-Salinas, A.; Moraleda, J.M.; Rodríguez-Otero, P.; Zabaleta, A.; Inogés, S.; López-Díaz de Cerio, A.; Paiva, B.; Prósper, F.; Reguera, J.L.; Pérez-Simón, J.A.; Martin-Antonio, B.
Source
In: The Lancet Oncology . (The Lancet Oncology, August 2023, 24(8):913-924)
Subject
Language
English
ISSN
14745488
14702045
14702045